Press release
Investigation announced for Long-Term Investors in BELLUS Health Inc. (NASDAQ: BLU)
An investigation on behalf of current long term investors in BELLUS Health Inc. (NASDAQ: BLU) shares.
Investors who are current long term investors in BELLUS Health Inc. (NASDAQ: BLU) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: BLU stocks follows a lawsuit filed against BELLUS Health Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: BLU stocks, concerns whether certain BELLUS Health directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges that, the defendants made false and/or misleading statements and/or failed to disclose information that resulted in a scheme that deceived the investing public regarding BELLUS Health Inc. 's business, operations, drug products, drug product development, competition, and present and future business prospects, that facilitated the Company's September 2019 public offering ("Offering"), that created artificial demand for the BELLUS Health Inc. common shares sold in the Offering, that enabled the Company to receive approximately $70 million in net proceeds from the sale of BELLUS Health Inc. common stock in the Offering, and that caused purchases of BELLUS Health Inc. publicly traded common stock at artificially inflated prices.
Those who purchased shares of BELLUS Health Inc. (NASDAQ: BLU) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in BELLUS Health Inc. (NASDAQ: BLU) here
News-ID: 2302917 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for BELLUS
Sarcoidosis Drug Market Size, Share, Growth 2021: Global Technology, Development …
Latest survey on Global Sarcoidosis Drug Market is conducted to provide hidden gems performance analysis to better demonstrate competitive environment of Sarcoidosis Drug Industry. The study is a mix of quantitative market stats and qualitative analytical information to uncover market size revenue breakdown by key business segments and end use applications. The report bridges the historical data from 2015 to 2021 and forecasted till 2028, the outbreak of latest scenario…
Deadline on May 17th coming up in Lawsuit for Investors in BELLUS Health Inc. (N …
A deadline is coming up on May 17, 2021 in the lawsuit filed for certain investors of BELLUS Health Inc. (NASDAQ: BLU) over alleged securities laws violations by BELLUS Health Inc.
Investors who purchased shares of BELLUS Health Inc. (NASDAQ: BLU) have certain options and there are strict and short deadlines running. Deadline: May 17, 2021. NASDAQ: BLU stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
Lawsuit filed for Investors in shares of BELLUS Health Inc. (NASDAQ: BLU)
An investor, who purchased shares of BELLUS Health Inc. (NASDAQ: BLU), filed a lawsuit over alleged violations of Federal Securities Laws by BELLUS Health Inc.
Investors who purchased shares of BELLUS Health Inc. (NASDAQ: BLU) have certain options and for certain investors are short and strict deadlines running. Deadline: May 17, 2021. NASDAQ: BLU investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Canada based BELLUS Health…
Sarcoidosis Drug Market : By Relief therapeutics holding SA, Firststring researc …
Sarcoidosis Drug Market Report examines the competitive scenario and gives all major players market share based on production capacity, sales, revenues, geographical presence and other important factors. The report includes a detailed description, a competitive scenario, a wide range of market leaders and business strategies adopted by competitors together with their SWOT analysis. It also provides explicit information about fusions, acquisitions, joint ventures and other important market activities in recent years.…
RF Microneedling Market Trends, Demand, Growth Opportunities To 2027 - Eclipse A …
RF Microneedling is a process that filters the face treating most types of acne scars, resurfacing skin color, tightening and firing aging skin and helping the face regain its volume. It delivers RF energy deep into the dermis enhancing the skin and reducing the scars of the face.
The report aims to provide an overview of RF Microneedling market with detailed market segmentation by Material, Device, Application, and geography. The global…
2019 RF Microneedling Market Presents Industry Insights & Depth Analysis Led by …
RF Microneedling Market to 2027 - Global Analysis and Forecasts by Material (Silicon Microneedle, Metal Microneedle, Glass Hollow Microneedle); Device (Derma-Stamp, Dermapen, Dermarollers); Application (Skin Rejuvenation, Acne Scar, Traumatic and Surgical Scars, Others)
RF Microneedling Market report is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market…
